Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,002 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E. Mercado N, et al. Among authors: gersh bj. J Thorac Cardiovasc Surg. 2005 Aug;130(2):512-9. doi: 10.1016/j.jtcvs.2004.12.049. J Thorac Cardiovasc Surg. 2005. PMID: 16077421 Free article.
Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial).
Mercado N, Brugts JJ, Ix JH, Shlipak MG, Dixon SR, Gersh BJ, Lemos PA, Guarneri M, Teirstein PS, Wijns W, Serruys PW, Boersma E, O'Neill WW. Mercado N, et al. Among authors: gersh bj. Am J Cardiol. 2008 Nov 1;102(9):1151-5. doi: 10.1016/j.amjcard.2008.06.035. Epub 2008 Aug 9. Am J Cardiol. 2008. PMID: 18940282 Clinical Trial.
Impact of Chronic Kidney Disease on Long-Term Outcomes in Type 2 Diabetic Patients With Coronary Artery Disease on Surgical, Angioplasty, or Medical Treatment.
Lima EG, Hueb W, Gersh BJ, Rezende PC, Garzillo CL, Favarato D, Hueb AC, Rahmi Garcia RM, Franchini Ramires JA, Filho RK. Lima EG, et al. Among authors: gersh bj. Ann Thorac Surg. 2016 May;101(5):1735-44. doi: 10.1016/j.athoracsur.2015.10.036. Epub 2016 Jan 12. Ann Thorac Surg. 2016. PMID: 26794894
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial.
Kappetein AP, Serruys PW, Sabik JF, Leon MB, Taggart DP, Morice MC, Gersh BJ, Pocock SJ, Cohen DJ, Wallentin L, Ben-Yehuda O, van Es GA, Simonton CA, Stone GW. Kappetein AP, et al. Among authors: gersh bj. EuroIntervention. 2016 Sep 18;12(7):861-72. doi: 10.4244/EIJV12I7A141. EuroIntervention. 2016. PMID: 27639738 Free article. Clinical Trial.
B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B, Chen S, Crowley A, Ben-Yehuda O, Gersh BJ, Lembo NJ, Brown WM 3rd, Banning AP, Taggart DP, Serruys PW, Kappetein AP, Sabik JF 3rd, Stone GW. Redfors B, et al. Among authors: gersh bj. Circulation. 2018 Jul 31;138(5):469-478. doi: 10.1161/CIRCULATIONAHA.118.033631. Circulation. 2018. PMID: 29666071 Clinical Trial.
Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.
Diamond J, Madhavan MV, Sabik JF 3rd, Serruys PW, Kappetein AP, Leon MB, Taggart DP, Berland J, Morice MC, Gersh BJ, Kandzari DE, Dressler O, Stone GW. Diamond J, et al. Among authors: gersh bj. JACC Cardiovasc Interv. 2018 Dec 24;11(24):2441-2450. doi: 10.1016/j.jcin.2018.09.008. JACC Cardiovasc Interv. 2018. PMID: 30573053 Free article. Clinical Trial.
Usefulness of Discharge Resting Heart Rate to Predict Adverse Cardiovascular Outcomes in Patients With Left Main Coronary Artery Disease Revascularized With Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting (from the EXCEL Trial).
Kosmidou I, Crowley A, Macedo L, Ben-Yehuda O, Gersh BJ, Boonstra PW, Kappetein AP, Serruys PW, Sabik JF 3rd, Stone GW. Kosmidou I, et al. Among authors: gersh bj. Am J Cardiol. 2020 Jan 15;125(2):169-175. doi: 10.1016/j.amjcard.2019.10.004. Epub 2019 Oct 26. Am J Cardiol. 2020. PMID: 31735328 Clinical Trial.
Outcomes After Left Main Coronary Artery Revascularization by Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting According to Smoking Status.
Shahim B, Redfors B, Chen S, Morice MC, Gersh BJ, Puskas JD, Kandzari DE, Merkely B, Horkay F, Crowley A, Serruys PW, Kappetein AP, Sabik JF 3rd, Ben-Yehuda O, Stone GW. Shahim B, et al. Among authors: gersh bj. Am J Cardiol. 2020 Jul 15;127:16-24. doi: 10.1016/j.amjcard.2020.04.029. Epub 2020 Apr 22. Am J Cardiol. 2020. PMID: 32360038 Clinical Trial.
The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results.
Hueb W, Soares PR, Gersh BJ, César LA, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramires JA. Hueb W, et al. Among authors: gersh bj. J Am Coll Cardiol. 2004 May 19;43(10):1743-51. doi: 10.1016/j.jacc.2003.08.065. J Am Coll Cardiol. 2004. PMID: 15145093 Free article. Clinical Trial.
1,002 results